January 14, 2026 Experience COAM International $2.4 billion MTN program update and offering We advised the arrangers, dealers and joint lead managers
January 12, 2026 Experience MiniMax Group HK$4.8 billion IPO We advised MiniMax Group on its IPO and HKEX listing
January 5, 2026 Experience Cinda HK $1.2 billion guaranteed and floating-rate notes offerings We advised the joint lead managers on the offering
December 31, 2025 Experience InSilico Medicine HK$2.62 billion IPO We advised InSilico Medicine on its IPO and HKEX listing
December 30, 2025 Experience Shenzhen Xunce Technology HK$1.08 billion IPO We advised Xunce on its IPO and HKEX listing
December 23, 2025 Experience PegBio HK$300 million placement of shares We advised PegBio on the placement of new shares
December 18, 2025 Experience HashKey Holdings HK$1.6 billion IPO We advised HashKey on its IPO and HKEX listing
December 17, 2025 Experience Pony AI HK$6.71 billion dual primary listing on the Hong Kong Stock Exchange We advised Pony AI on its dual primary listing on HKEX
December 15, 2025 Experience Biocytogen RMB1.27 billion Shanghai IPO We advised Biocytogen on its IPO and SSE listing
December 12, 2025 Experience Seyond Holdings HK$11.7 billion de-SPAC transaction and private placement We advised Seyond on the transactions